Chemoinformaics analysis of Rhodiolgidin
Molecular Weight | 626.52 | nRot | 6 |
Heavy Atom Molecular Weight | 596.28 | nRig | 30 |
Exact Molecular Weight | 626.148 | nRing | 5 |
Solubility: LogS | -3.953 | nHRing | 3 |
Solubility: LogP | -0.31 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 2 |
nHetero | 17 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 30 | No. of Saturated Hetero Cycles | 2 |
No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 17 | No. of Arom Bond | 17 |
nHA | 17 | APOL | 78.7278 |
nHD | 11 | BPOL | 39.6442 |
QED | 0.128 |
Synth | 4.905 |
Natural Product Likeliness | 2.008 |
NR-PPAR-gamma | 0.168 |
Lipinski | Rejected |
Pfizer | Accepted |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.011 |
Pgp-sub | 0.994 |
HIA | 0.837 |
CACO-2 | -6.615 |
MDCK | 0.00004 |
BBB | 0.035 |
PPB | 0.821572 |
VDSS | 0.703 |
FU | 0.190175 |
CYP1A2-inh | 0.07 |
CYP1A2-sub | 0.022 |
CYP2c19-inh | 0.014 |
CYP2c19-sub | 0.05 |
CYP2c9-inh | 0.004 |
CYP2c9-sub | 0.072 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.113 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.001 |
CL | 1.341 |
T12 | 0.737 |
hERG | 0.206 |
Ames | 0.877 |
ROA | 0.023 |
SkinSen | 0.806 |
Carcinogencity | 0.034 |
EI | 0.105 |
Respiratory | 0.015 |
NR-Aromatase | 0.645 |
Antiviral | Yes |
Prediction | 0.779354 |